ストックスクリーナーアプリを入手
1.87
1.06%
-0.02
アフターアワーズ：
1.91
0.04
+2.14%
前日終値:
$1.89
開ける：
$1.91
24時間の取引高:
115.25K
Relative Volume:
0.28
時価総額：
$98.12M
収益：
$21.05M
当期純損益:
$-89.22M
株価収益率:
-1.0447
EPS:
-1.79
ネットキャッシュフロー:
$-64.50M
1週間 パフォーマンス:
+10.00%
1か月 パフォーマンス:
-3.11%
6か月 パフォーマンス:
-7.43%
1年 パフォーマンス:
-66.18%
1日の値動き範囲:
$1.865
$1.95
1週間の範囲:
$1.66
$1.95
52週間の値動き範囲:
$1.02
$6.225
Tscan Therapeutics Inc Stock (TCRX) Company Profile
TCRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TCRX
Tscan Therapeutics Inc
|
1.87 | 107.25M | 21.05M | -89.22M | -64.50M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-16 | 開始されました | BTIG Research | Buy |
| 2024-05-13 | 開始されました | Needham | Buy |
| 2023-06-22 | 開始されました | Wedbush | Outperform |
Tscan Therapeutics Inc (TCRX) 最新ニュース
What data driven models say about TScan Therapeutics Inc.’s future2025 Year in Review & Low Drawdown Momentum Ideas - Newser
Historical volatility pattern of TScan Therapeutics Inc. visualizedWeekly Stock Analysis & Daily Price Action Insights - Newser
How high can TScan Therapeutics Inc. stock goPortfolio Growth Summary & Accurate Entry and Exit Point Alerts - Newser
Full technical analysis of TScan Therapeutics Inc. stockJuly 2025 Technicals & Fast Exit Strategy with Risk Control - Newser
Does TScan Therapeutics Inc. fit your quant trading modelRisk Management & Verified Short-Term Trading Plans - Newser
Identifying reversal signals in TScan Therapeutics Inc.Forecast Cut & High Win Rate Trade Alerts - Newser
Sector ETF performance correlation with TScan Therapeutics Inc.Gap Down & Safe Entry Point Alerts - Newser
What recovery options are there for TScan Therapeutics Inc.Market Trend Review & Step-by-Step Trade Execution Guides - Newser
Volatility clustering patterns for TScan Therapeutics Inc.Trade Exit Summary & Reliable Price Breakout Alerts - Newser
Visualizing TScan Therapeutics Inc. stock with heatmapsEarnings Miss & Daily Entry Point Alerts - Newser
Quant Strategy Flags TScan Therapeutics Inc. for EntryMarket Activity Report & Short-Term High Return Ideas - classian.co.kr
Real time scanner hits for TScan Therapeutics Inc. explainedJuly 2025 Market Mood & Precise Entry and Exit Recommendations - Newser
Is TScan Therapeutics Inc. stock forming a cup and handleTrend Reversal & AI Forecasted Entry/Exit Points - theviewers.co.kr
What moving averages say about TScan Therapeutics Inc.July 2025 Movers & Safe Capital Growth Trade Ideas - Newser
Is TScan Therapeutics Inc.’s ROE strong enoughWeekly Trade Analysis & Expert Approved Momentum Trade Ideas - theviewers.co.kr
Can TScan Therapeutics Inc. deliver consistent dividendsPortfolio Profit Report & Weekly High Potential Alerts - theviewers.co.kr
Order flow analysis tools used on TScan Therapeutics Inc.Weekly Loss Report & Verified Stock Trade Ideas - Newser
TScan Therapeutics Inc. Forms Bullish Flag — Upside Ahead2025 Top Gainers & Fast Gain Swing Trade Alerts - classian.co.kr
TScan Therapeutics Inc.’s Beta Climbs After Market VolatilityJuly 2025 Sentiment & Precise Buy Zone Tips - beatles.ru
Growth Report: What are analysts’ price targets for TScan Therapeutics Inc.July 2025 Technicals & Free Safe Entry Trade Signal Reports - kpenews.com
TScan Therapeutics Inc. recovery potential after sell offQuarterly Profit Report & Technical Entry and Exit Tips - Newser
TScan Therapeutics, Inc. Announces Appointment of Leiden Dworak as Principal Accounting Officer, Effective August 14, 2025 - MarketScreener
Statistical indicators supporting TScan Therapeutics Inc.’s strengthJuly 2025 Institutional & Expert Approved Trade Ideas - Newser
Combining machine learning predictions for TScan Therapeutics Inc.July 2025 Earnings & Smart Investment Allocation Insights - Newser
TScan Therapeutics Inc. stock trend forecastPortfolio Performance Summary & Stepwise Swing Trade Plans - Newser
What is Lifesci Capital’s Forecast for TCRX FY2025 Earnings? - Defense World
HC Wainwright Expects Higher Earnings for TScan Therapeutics - Defense World
Detecting price anomalies in TScan Therapeutics Inc. with AIJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - Newser
TScan Therapeutics Inc. Shows Support at Fibonacci LevelWatch List & Technical Entry and Exit Alerts - sundaytimes.kr
What are analysts’ price targets for TScan Therapeutics Inc.2025 Winners & Losers & Real-Time Volume Analysis - mustnews.co.kr
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates - MSN
Tscan Therapeutics Inc (TCRX) 財務データ
収益
当期純利益
現金流量
EPS
Tscan Therapeutics Inc (TCRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
May 20 '25 |
Buy |
1.20 |
1,200,000 |
1,440,000 |
7,946,141 |
| Lynx1 Capital Management LP | 10% Owner |
Dec 13 '24 |
Buy |
2.90 |
100,000 |
290,140 |
5,357,347 |
| Lynx1 Capital Management LP | 10% Owner |
Dec 12 '24 |
Buy |
3.01 |
31,800 |
95,629 |
5,257,347 |
| Lynx1 Capital Management LP | 10% Owner |
Nov 15 '24 |
Buy |
4.34 |
947 |
4,114 |
5,225,547 |
| Klencke Barbara | Director |
Sep 23 '24 |
Buy |
5.29 |
5,000 |
26,450 |
45,000 |
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):